A recent Phase 3 trial showed people with radiologically isolated syndrome (RIS) who took Aubagio were 72 percent less likely to later develop MS symptoms.
France: A preliminary study showed a drug called teriflunomide to delay the earliest symptoms of multiple sclerosis. The study s findings will be presented at the American Academy of Neurology’s 75th.
A drug called teriflunomide may delay first symptoms for people whose magnetic resonance imaging (MRI) scans show signs of multiple sclerosis (MS) even though they do not yet have symptoms of the disease.